Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis
about
Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so farEndocannabinoid Signaling Regulates Sleep StabilityEndocannabinoid signaling in the etiology and treatment of major depressive illness.Role of N-Arachidonoyl-Serotonin (AA-5-HT) in Sleep-Wake Cycle Architecture, Sleep Homeostasis, and Neurotransmitters RegulationAdministration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats.Endocannabinoid signalling: has it got rhythm?Cannabis and the brain.Comparison of novel cannabinoid partial agonists and SR141716A in the guinea-pig small intestineThe CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions.The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolaseEndocannabinoid modulation of cortical up-states and NREM sleep.Multiple sleep alterations in mice lacking cannabinoid type 1 receptors.Manipulation of the endocannabinoid system by a general anaestheticNeurobiological Interactions Between Stress and the Endocannabinoid System.Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortexDose-dependent cannabis use, depressive symptoms, and FAAH genotype predict sleep quality in emerging adults: a pilot studyBiochemical modulation of the sleep-wake cycle: endogenous sleep-inducing factors.Vanilloid VR1 receptor is involved in rimonabant-induced neuroprotection.Cannabinoid signaling in health and disease.Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder.Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation.Modulation of food consumption and sleep-wake cycle in mice by the neutral CB1 antagonist ABD459A Pilot Study into the Effects of the CB1 Cannabinoid Receptor Agonist WIN55,212-2 or the Antagonist/Inverse Agonist AM251 on Sleep in Rats.Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex.Characterization of a novel, brain-penetrating CB1 receptor inverse agonist: metabolic profile in diet-induced obese models and aspects of central activity.Neurophysiological evidence for the presence of cannabinoid CB1 receptors in the laterodorsal tegmental nucleus.Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series.
P2860
Q21090468-F5888383-0BA9-4260-AD45-E274C5279743Q27316124-C9A5E982-F7E4-470B-A19B-573DC2EB93E4Q30687668-A935DD2C-A315-4253-89EF-2AFD669A8BACQ33736469-2A55F28A-2756-471B-8E46-294F48302B11Q33968029-B2C29C12-F98A-4039-BB2E-54201CFE755EQ34098217-4E67F2A7-B8AF-4619-848B-3A17C296DB0DQ34199483-24DB4C69-9974-42EA-BCAC-BF8CAC3F3E5DQ35041929-3F3EC35E-CF52-4111-AA48-759B9AECDAEFQ35045001-99C811BA-932B-4F37-B9CF-CB5842057B2FQ35045476-336668EA-3D73-43B3-AE26-7567B32EC259Q35092892-4CF6B08F-A979-474D-AF76-740812E55077Q35107312-003F068D-4430-490B-902D-74A3FADB0A26Q35168593-E094BB94-2035-4C9C-AEA4-70EA805C1B0BQ36366731-5586BD05-AC99-44AB-8CEE-0AF0F181F77AQ37240007-F45DC85A-BC0A-44C1-8EFE-79C7A1F0FF1BQ37621129-D9C0A329-D4CD-4629-9F0C-9763DE027EB5Q37873882-A56B8D1F-C98A-4E19-82B3-9BA52908F589Q38756777-A1D4D8EE-66D7-481E-BB21-B20E0C130871Q39163671-7E0F1C84-9556-4B1D-8C3F-876E3407DE58Q39459073-0E7E2C3F-2D67-488A-9232-3BFC48E15E60Q40653236-16F81215-48B6-48AD-8E97-5B5B29129425Q41152430-F94346B5-67AE-47F1-8184-498357BE77FDQ41811457-FB6F138A-81AF-454C-A9CB-DF9FABAA8531Q41905626-4512A7E0-8D58-4241-A909-5844AC7347B0Q43432897-D13C9F57-F093-4434-8375-F08AEAC716C4Q47725960-7EC0965C-5B5A-4A2E-8FB4-1E5D08689156Q48105623-D9A3F3BA-A888-4689-8EA7-0E1A360CE6A0
P2860
Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis
description
1996 nî lūn-bûn
@nan
1996 թուականին հրատարակուած գիտական յօդուած
@hyw
1996 թվականին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Arousal-enhancing properties o ...... nd sleep-waking cycle analysis
@ast
Arousal-enhancing properties o ...... nd sleep-waking cycle analysis
@en
Arousal-enhancing properties o ...... nd sleep-waking cycle analysis
@nl
type
label
Arousal-enhancing properties o ...... nd sleep-waking cycle analysis
@ast
Arousal-enhancing properties o ...... nd sleep-waking cycle analysis
@en
Arousal-enhancing properties o ...... nd sleep-waking cycle analysis
@nl
prefLabel
Arousal-enhancing properties o ...... nd sleep-waking cycle analysis
@ast
Arousal-enhancing properties o ...... nd sleep-waking cycle analysis
@en
Arousal-enhancing properties o ...... nd sleep-waking cycle analysis
@nl
P2093
P921
P3181
P1433
P1476
Arousal-enhancing properties o ...... nd sleep-waking cycle analysis
@en
P2093
P304
P3181
P356
10.1016/0024-3205(95)02319-4
P407
P577
1996-01-01T00:00:00Z